59 related articles for article (PubMed ID: 17196140)
1. [The importance of using ribavirin in treating chronic hepatitis C].
Xie Y; Li MH
Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):930-1. PubMed ID: 17196140
[No Abstract] [Full Text] [Related]
2. Ribavirin as maintenance therapy for hepatitis C patients: an interim peacekeeper?
Patel K; Dev A; Muir AJ; McHutchison JG
Hepatology; 2003 Jul; 38(1):21-4. PubMed ID: 12829982
[No Abstract] [Full Text] [Related]
3. [Ribavirin: a new drug in the treatment of chronic hepatitis C].
Salmerón J
Gastroenterol Hepatol; 1997; 20(7):363-5. PubMed ID: 9377236
[No Abstract] [Full Text] [Related]
4. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
Soza A; Hoofnagle JH
Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
[No Abstract] [Full Text] [Related]
5. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
Zeuzem S
Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
[No Abstract] [Full Text] [Related]
6. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
Forns Bernhardt X
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
[No Abstract] [Full Text] [Related]
7. Combination therapy for chronic hepatitis C.
Marcellin P
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):135-6. PubMed ID: 10363199
[No Abstract] [Full Text] [Related]
8. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders.
Glaser D
Am J Gastroenterol; 2000 Nov; 95(11):3315-6. PubMed ID: 11095370
[No Abstract] [Full Text] [Related]
9. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
[No Abstract] [Full Text] [Related]
10. [Ribavirin].
Taéron C
Rev Infirm; 2009; (152):47-9. PubMed ID: 19702029
[No Abstract] [Full Text] [Related]
11. Mutagenic effects of ribavirin in vivo.
Perelson AS; Ribeiro RM
J Hepatol; 2005 Oct; 43(4):553-5. PubMed ID: 16099528
[No Abstract] [Full Text] [Related]
12. [Treatment of chronic hepatitis C in patients without previous treatment].
Dehesa Violante M
Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C: current and future therapies.
Mishra P; Jensen DM
Mt Sinai J Med; 2008 Aug; 75(4):405-14. PubMed ID: 18729159
[No Abstract] [Full Text] [Related]
14. Rapid virological response in hepatitis C virus genotype 1 and early ribavirin exposure.
Dai CY; Chuang WL; Huang JF; Hsieh MY; Yu ML
Hepatology; 2008 Aug; 48(2):692-3; author reply 693-4. PubMed ID: 18666250
[No Abstract] [Full Text] [Related]
15. [Treatment of chronic hepatitis C: present and future].
Hezode C; Dhumeaux D
Gastroenterol Clin Biol; 2000 May; 24(5):533-5. PubMed ID: 10891741
[No Abstract] [Full Text] [Related]
16. [Management of chronic hepatitis in 2008].
Pol S; Marcellin P
Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S71-3. PubMed ID: 18675183
[No Abstract] [Full Text] [Related]
17. The next step for taribavirin.
Kwo PY; Vinayek R
Hepatology; 2010 Oct; 52(4):1185-8. PubMed ID: 20879028
[No Abstract] [Full Text] [Related]
18. Ribavirin and immune thrombocytopenic purpura.
Jaccard A; Loustaud V; Turlure P; Rogez S; Bordessoule D
Lancet; 1998 May; 351(9116):1660-1. PubMed ID: 9620744
[No Abstract] [Full Text] [Related]
19. With all the new treatment regimens, complete elimination of hepatitis C virus in Canada is a possibility! But when will Canadians have access these drugs?
Peltekian KM
Can J Gastroenterol Hepatol; 2014 Sep; 28(8):417-8. PubMed ID: 25229463
[No Abstract] [Full Text] [Related]
20. Ribavirin ante portas: uptake transporters into hepatocytes dissected.
Bengsch B; Thimme R
J Hepatol; 2010 Apr; 52(4):469-71. PubMed ID: 20185189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
